By
AmyT on
November 10, 2008
On Wednesday of this week, the eighth annual Diabetes Technology Meeting convenes in Bethesda, MD, for a three-day event (spanning this year’s World Diabetes Day on Thursday) that will survey the latest technological advances for people with diabetes. How I’d love to be a fly on the wall at that conference!
Nevermind that I’ve been trying to gain press access to this meeting for at least the last 3 years; I have a mole this…
Read more »
By
AmyT on
November 4, 2008
Again, Januvia is one of the most searched-for terms on this site — which is interesting, because it’s an oral drug for controlling Type 2 diabetes with which I have no personal experience. But there’s a “perfect storm” surrounding Januvia that encapsulates many of the controversial themes running through diabetes care:
Show Me the Money
If you recall, Januvia is an oral DPP-4 inhibitor that lowers blood sugar by inhibiting glucagon release, versus the GLP-1…
Read more »
By
AmyT on
November 3, 2008
Imagine: Smart Insulin that could sense high glucose levels and automatically dispense insulin on demand. “As your glucose levels drop off, the drug stabilizes, trapping insulin until the next glucose spike.” WOW! So it knows if you’ve been bad or good and just jumps right in there to correct your BG like a healthy pancreas?!
You are kidding me, right? Weeeelll, not according to Todd Zion, founder and CEO of SmartCells, a privately held company…
Read more »
By
AmyT on
October 29, 2008
I met Alexis at the recent BDI luncheon for women with Type 1 diabetes. She seemed bubbly and smart, and I felt an instant connection. When I discovered her job title was “Compliance Analyst,” I just had to hear more about that. Turns out it’s not quite what you think, but fascinating nevertheless.
A Guest Post by Alexis Pollack —
Compliance Analyst, Amylin Pharmaceuticals, Inc.
Type 1 diabetes for 15 years
Compliance. It’s not a…
Read more »
By
AmyT on
October 25, 2008
This just in from Diabetic Investor David Kliff:
“Animas®, the insulin pump unit of Johnson and Johnson (NYSE:JNJ), will be recalling the new OneTouch® Ping™ blood glucose monitor that works in conjunction with the Animas 2020 insulin pump. Apparently the problem resides with the Ping and not the insulin pump. When the two units are not synched, communicating with each other, the bolus calculator on the Ping does not work properly. The bolus calculator is…
Read more »